Kyverna Therapeutics, Inc. (KYTX) Insider Ownership

Historic Insider Ownership Trends

As of June 18, 2026, the three largest insider holders of KYTX are Ventures, Llc Vida (TenPercentOwner, 4.78Mn shares), Fred E Cohen (Director, 4.52Mn shares), Sciences, Inc. Gilead (TenPercentOwner, 4.13Mn shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares (Direct) Shares (Indirect) Report Date
Sciences, Inc. Gilead - 4,126,119 0 13 Feb, 2024
Beth C Seidenberg - 0 869,317 22 Dec, 2025
Ian T Clark - 16,634 0 02 Jun, 2025
Fred E Cohen - 0 4,523,924 14 Feb, 2024
Christi Shaw Executive Chairperson 70,935 0 14 Jan, 2026
Capital Life Sciences Investors, Llc Bain - 0 3,163,868 14 Feb, 2024
Ventures, Llc Vida - 0 4,777,060 14 Feb, 2024
Marc Grasso Chief Financial Officer 10,000 0 17 Mar, 2026
Biopartners Fund I, L.P. Westlake - 0 735,984 14 Feb, 2024
Andrew Craig Miller - 11,006 0 04 Mar, 2026
Biopartners Opportunity Fund I, L.P. Westlake - 0 869,317 22 Dec, 2025
Sravan Kumar Emany - 11,006 0 26 Feb, 2026
Ryan Alexander Jones Chief Financial Officer 55,950 0 15 Apr, 2025
Karen Marie Walker Chief Technology Officer 22,636 0 17 Dec, 2025
Ventures Iii Gp, Llc Northpond - 0 3,255,426 12 Feb, 2024
Warner Weston Biddle Chief Executive Officer 58,000 0 17 Mar, 2026
Mert Aktar - 16,634 0 02 Jun, 2025
Naji Gehchan - 18,000 0 17 Mar, 2026

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
13 Mar, 2026 Warner Weston Biddle Common Stock A 58,000 $0.00 58,000 D A
13 Mar, 2026 Marc Grasso Common Stock A 10,000 $0.00 10,000 D A
13 Mar, 2026 Naji Gehchan Common Stock A 18,000 $0.00 18,000 D A
13 Mar, 2026 Marc Grasso Stock Option (right to buy) A 65,000 $0.00 65,000 D A
13 Mar, 2026 Warner Weston Biddle Stock Option (right to buy) A 350,000 $0.00 350,000 D A
13 Mar, 2026 Naji Gehchan Stock Option (right to buy) A 105,000 $0.00 105,000 D A
24 Feb, 2026 Andrew Craig Miller Common Stock A 11,006 $0.00 11,006 D A
24 Feb, 2026 Andrew Craig Miller Common Stock A 11,006 $0.00 11,006 D A
24 Feb, 2026 Andrew Craig Miller Stock Option (right to buy) A 42,945 $0.00 42,945 D A
24 Feb, 2026 Andrew Craig Miller Stock Option (right to buy) A 42,945 $0.00 42,945 D A
24 Feb, 2026 Sravan Kumar Emany Common Stock A 11,006 $0.00 11,006 D A
24 Feb, 2026 Sravan Kumar Emany Stock Option (right to buy) A 42,945 $0.00 42,945 D A
09 Feb, 2026 Mayobanex Pujols Stock Option (right to buy) A 300,000 $0.00 300,000 D A
09 Feb, 2026 Mayobanex Pujols Stock Option (right to buy) A 300,000 $0.00 300,000 D A
12 Jan, 2026 Christi Shaw Common Stock A 30,000 $0.00 46,634 D A
12 Jan, 2026 Christi Shaw Common Stock A 30,000 $0.00 46,634 D A
12 Jan, 2026 Christi Shaw Common Stock A 24,301 $0.00 70,935 D A
12 Jan, 2026 Christi Shaw Common Stock A 24,301 $0.00 70,935 D A
12 Jan, 2026 Christi Shaw Stock Option (right to buy) A 185,000 $0.00 185,000 D A
12 Jan, 2026 Christi Shaw Stock Option (right to buy) A 185,000 $0.00 185,000 D A